Mainz Biomed B.V. (MYNZ)

USD 3.14

(-0.32%)

Operating Expenses Summary of Mainz Biomed B.V.

  • Mainz Biomed B.V.'s latest annual operating expenses in 2023 was 27.15 Million USD , up 3.03% from previous year.
  • Mainz Biomed B.V.'s latest quarterly operating expenses in 2023 FY was 27.15 Million USD , up 3.03% from previous quarter.
  • Mainz Biomed B.V. reported a annual operating expenses of 26.35 Million USD in annual operating expenses 2022, up 175.79% from previous year.
  • Mainz Biomed B.V. reported a annual operating expenses of 9.55 Million USD in annual operating expenses 2021, up 1893.57% from previous year.
  • Mainz Biomed B.V. reported a quarterly operating expenses of 6.62 Million USD for 2023 Q1, down -20.42% from previous quarter.
  • Mainz Biomed B.V. reported a quarterly operating expenses of 27.15 Million USD for 2023 FY, up 3.03% from previous quarter.

Annual Operating Expenses Chart of Mainz Biomed B.V. (2023 - 2019)

Created with Highcharts 11.1.0YearsOperating Expenses20192019.520202020.520212021.520222022.520230 USD10000000 USD20000000 USD30000000 USD

Historical Annual Operating Expenses of Mainz Biomed B.V. (2023 - 2019)

Year Operating Expenses Operating Expenses Growth
2023 27.15 Million USD 3.03%
2022 26.35 Million USD 175.79%
2021 9.55 Million USD 1893.57%
2020 479.38 Thousand USD -30.55%
2019 690.21 Thousand USD 0.0%

Peer Operating Expenses Comparison of Mainz Biomed B.V.

Name Operating Expenses Operating Expenses Difference
Aclaris Therapeutics, Inc. 110.52 Million USD 75.431%
Applied DNA Sciences, Inc. 16.48 Million USD -64.704%
Aspira Women's Health Inc. 24.11 Million USD -12.608%
Biodesix, Inc. 77.41 Million USD 64.925%
BioNexus Gene Lab Corp. 3.92 Million USD -592.168%
bioAffinity Technologies, Inc. 8.76 Million USD -209.81%
bioAffinity Technologies, Inc. 8.76 Million USD -209.81%
Bionano Genomics, Inc. 148.99 Million USD 81.775%
CareDx, Inc 277.76 Million USD 90.224%
Check-Cap Ltd. 19.28 Million USD -40.791%
Castle Biosciences, Inc. 242.78 Million USD 88.815%
DarioHealth Corp. 62.17 Million USD 56.325%
Exact Sciences Corporation 2.06 Billion USD 98.682%
Fulgent Genetics, Inc. 171.9 Million USD 84.204%
Guardant Health, Inc. 901.62 Million USD 96.988%
ICON Public Limited Company 755.64 Million USD 96.406%
IDEXX Laboratories, Inc. 1.09 Billion USD 97.515%
Illumina, Inc. 3.81 Billion USD 99.288%
Intelligent Bio Solutions Inc. 11.7 Million USD -131.914%
iSpecimen Inc. 16.27 Million USD -66.824%
Standard BioTools Inc. 113.48 Million USD 76.073%
MDxHealth SA 71.25 Million USD 61.892%
23andMe Holding Co. 420.73 Million USD 93.546%
Medpace Holdings, Inc. 187.68 Million USD 85.532%
Myriad Genetics, Inc. 600.1 Million USD 95.475%
ENDRA Life Sciences Inc. 10.52 Million USD -158.103%
NeoGenomics, Inc. 341.25 Million USD 92.043%
Neogen Corporation 405.23 Million USD 93.299%
Inotiv, Inc. 246.9 Million USD 89.002%
Natera, Inc. 938.98 Million USD 97.108%
OpGen, Inc. 30.65 Million USD 11.428%
OPKO Health, Inc. 574.68 Million USD 95.275%
Psychemedics Corporation 11.33 Million USD -139.583%
Prenetics Global Limited 60.73 Million USD 55.292%
Prenetics Global Limited 60.73 Million USD 55.292%
Precipio, Inc. 13.63 Million USD -99.108%
Personalis, Inc. 128.14 Million USD 78.81%
RadNet, Inc. 268.87 Million USD 89.901%
Sera Prognostics, Inc. 39.91 Million USD 31.973%
Sotera Health Company 300.46 Million USD 90.963%
Neuronetics, Inc. 82.25 Million USD 66.989%
Star Equity Holdings, Inc. 16.27 Million USD -66.878%
Star Equity Holdings, Inc. 16.27 Million USD -66.878%
Trinity Biotech plc 46.49 Million USD 41.597%
T2 Biosystems, Inc. 41.49 Million USD 34.558%
Twist Bioscience Corporation 354.18 Million USD 92.333%
Exagen Inc. 52.29 Million USD 48.073%